U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07464028) titled 'Terazosin And Metabolic Energetics in Parkinson's Disease' on March 05.
Brief Summary: This study investigates if Terazosin can improve metabolism in PD.
Study Start Date: July 01, 2026
Study Type: INTERVENTIONAL
Condition:
Parkinson's Disease (PD)
Intervention:
DRUG: Terazosin 5 MG
This drug increases glycolysis in Parkinson's disease.
DRUG: Placebo
Placebo control for Terazosin
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Nandakumar Narayanan
Information provided by (Responsible Party): Nandakumar Narayanan, University of Iowa
Published by HT Digital Content Services with permission from Health Daily Digest....